Wahr J A, Parks R, Boisvert D, Comunale M, Fabian J, Ramsay J, Mangano D T
Department of Anesthesiology, University of Michigan, Ann Arbor, USA.
JAMA. 1999 Jun 16;281(23):2203-10. doi: 10.1001/jama.281.23.2203.
Although potassium is critical for normal electrophysiology, the association between abnormal preoperative serum potassium level and perioperative adverse events such as arrhythmias has not been examined rigorously.
To determine the prevalence of abnormal preoperative serum potassium levels and whether such abnormal levels are associated with adverse perioperative events.
Prospective, observational, case-control study of data collected from 24 diverse US medical centers in a 2-year period from September 1, 1991, to September 1, 1993.
A total of 2402 patients (mean [SD] age, 65.1 [10.3] years; 24% female) undergoing elective coronary artery bypass grafting who were not enrolled in another protocol. The study population was identified using systematic sampling of every nth patient, in which n was based on expected total number of procedures at that center during the study period.
Intraoperative and postoperative arrhythmias, the need for cardiopulmonary resuscitation (CPR), cardiac death, and death due to any cause prior to discharge, by preoperative serum potassium level.
Perioperative arrhythmias occurred in 1290 (53.7%) of 2402 patients, with 238 patients (10.7%) having intraoperative arrhythmias, 329 (13.7%) having postoperative nonatrial arrhythmias, and 865 (36%) having postoperative atrial flutter or fibrillation. The incidence of adverse outcomes was 3.6% for death, 2.0% for cardiac death, and 3.5% for CPR. Serum potassium level less than 3.5 mmol/L was a predictor of serious perioperative arrhythmia (odds ratio [OR], 2.2; 95% confidence interval [CI], 1.2-4.0), intraoperative arrhythmia (OR, 2.0; 95% CI, 1.0-3.6), and postoperative atrial fibrillation/flutter (OR, 1.7; 95% CI, 1.0-2.7), and these relationships were unchanged after adjusting for confounders. The significant univariate association between increased need for CPR and serum potassium level less than 3.3 mmol/L (OR, 3.3; 95% CI, 1.2-9.5) and greater than 5.2 mmol/L (OR, 3.0; 95% CI, 1.1-8.7) became nonsignificant after adjusting for confounders.
Perioperative arrhythmia and the need for CPR increased as preoperative serum potassium level decreased below 3.5 mmol/L. Although interventional trials are required to determine whether preoperative intervention mitigates these adverse associations, preoperative repletion is low cost and low risk, and our data suggest that screening and repletion be considered in patients scheduled for cardiac surgery.
尽管钾对于正常的电生理功能至关重要,但术前血清钾水平异常与围手术期不良事件(如心律失常)之间的关联尚未得到严格研究。
确定术前血清钾水平异常的发生率,以及这种异常水平是否与围手术期不良事件相关。
1991年9月1日至1993年9月1日的两年期间,对美国24个不同医疗中心收集的数据进行前瞻性、观察性、病例对照研究。
共有2402例接受择期冠状动脉搭桥术的患者(平均[标准差]年龄为65.1[10.3]岁;24%为女性),且未参加其他方案。通过对每隔n例患者进行系统抽样来确定研究人群,其中n基于该中心在研究期间预期的手术总数。
根据术前血清钾水平,观察术中及术后心律失常、心肺复苏(CPR)需求、心源性死亡以及出院前任何原因导致的死亡情况。
2402例患者中有1290例(53.7%)发生围手术期心律失常,其中238例(10.7%)发生术中心律失常,329例(13.7%)发生术后非房性心律失常,865例(36%)发生术后心房扑动或颤动。不良结局的发生率为:死亡3.6%,心源性死亡2.0%,CPR 3.5%。血清钾水平低于3.5 mmol/L是严重围手术期心律失常(比值比[OR],2.2;95%置信区间[CI],1.2 - 4.0)、术中心律失常(OR,2.0;95% CI,1.0 - 3.6)和术后心房颤动/扑动(OR,1.7;95% CI,1.0 - 2.7)的预测因素,在调整混杂因素后这些关系不变。CPR需求增加与血清钾水平低于3.3 mmol/L(OR,3.3;95% CI,1.2 - 9.5)和高于5.2 mmol/L(OR,3.0;95% CI,1.1 - 8.7)之间的显著单因素关联在调整混杂因素后变得不显著。
随着术前血清钾水平降至3.5 mmol/L以下,围手术期心律失常和CPR需求增加。尽管需要进行干预性试验来确定术前干预是否能减轻这些不良关联,但术前补充钾成本低、风险低,我们的数据表明,对于计划进行心脏手术的患者应考虑进行筛查和补充。